Review Article on Aspirin for prevention of cancer-A potential!
Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2017, Vol 6, Issue 4
Abstract
Cancer has been a worldwide threat now with millions of cases of morbidity and mortality owing to it. According to the World Health Organization (WHO), cancer accounted for 8.2 million deaths worldwide by 2012 and its prevalence is predicted to increase in the next decade. There are, however, new data that reinforce the notion that low-dose aspirin intake may also help to prevent cancer and prevent the multiplying of cancer cells. Over the last few years, many studies have combated or supported the substantiation of the relationship between aspirin and cancer that have awakened the interest of researchers in this area. Many studies with follow-up period as long as 20 years have been carried out to analyze the effect that regular use of low-dose aspirin (75-300mg) can have on cancer prevention, especially colorectal cancer and the results have been promising. With the comprehensive analysis of risks and benefits and the linking evidences showing that aspirin, at low doses, can lower the risk of developing colorectal cancer by 40%, the U.S. Preventive Services Task Force (USPSTF) in 2015 released a draft recommendation around the use of aspirin to help prevent cardiovascular disease and colorectal cancer. The guidance was later released in April 2016. By far, there have been evidences for both COX-dependent and COX-independent mechanisms in aspirin cancer prevention. Based on the data that we have from various RCT’s and pharmacovigilance sources, the safety profile of aspirin looks reasonably good with the most commonly reported adverse event being Gastrointestinal bleeding. Although some clinical trials have shown that the risk may only be modest it however, cannot be ignored
Authors and Affiliations
Riju Pathak| Pharm.D, Krupanidhi College of Pharmacy, Chikka Bellandur, Carmellaram Post, Varthur Hobli, Bangalore-35, Patel Trushitkumar B| Pharm.D, Krupanidhi College of Pharmacy, Chikka Bellandur, Carmellaram Post, Varthur Hobli, Bangalore-35
Keywords
Related Articles
- EP ID EP4151
- DOI -
- Views 447
- Downloads 23
FORMULATION AND EVALUATION OF IMMEDIATE RELEASE TABLETS OF FLUNARIZINE DI-HYDROCHLORIDE
Immediate release tablets have started gaining popularity and acceptance as a drug delivery system, mainly because they are easy to administer, has quick onset of action, economical and lead to better patient compliance....
Method Development and Validation of Montelukast in Bulk and Pharmaceutical Dosage form by RP-HPLC
The present work describes a simple, precise and accurate HPLC method for estimation of montelukast sodium in bulk and in tablet dosage form. Montelukast sodium is a selective and orally active leukotriene receptor antag...
EFFECT OF POSTMENOPAUSAL STATUS ON SERUM LIPIDS PROFILE AND URIC ACID IN SUDANESE FEMALES FROM THE GENERAL POPULATION
BACKGROUND: Previous data suggest possible effects of postmenopause on serum lipids profile and uric acid which are established risk factors for cardiovascular system. AIM: to evaluate the changes that may occur on ser...
Informed Consent: A Mandatory Step in Clinical Trials.
Voluntary written consent given by potential subjects to participate in a clinical trial is known an informed consent. The informed consent process is designed keeping in mind the safety, benefits and rights of the resea...
ANALYSIS OF PRIMARY METABOLITES FROM VERTICILLIUMLECANII AND STUDIED ITS IMMUNOLOGICAL ASPECTS OF CRUDE PROTEASE AGAINST RAPITHER-AB
Objective- The objective of our study is to examine its primary metabolites (protein content) from dried powder of Verticilliumlecanii. In addition, immunological studies were conducted in order to analyzing the protease...